Lexicon Pharmaceuticals to Report Fourth Quarter 2025 Financial Results on March 5, 2026 THE WOODLANDS, Texas, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its fourth quarter 2025 financial results on Thursday, March 5, 2026, prior to market open. Management will conduct a conference call and live webcast at 8:30 a.m. ET (7:30 a.m. CT) that day to discuss the financial results and to provide a business update. Participants can access the conference call live via webcast on the Events page of the Company’s website ...
A director at Lexicon Pharmaceuticals Inc bought 268,497 shares at 1.314USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
Moody's Ratings (Moody's) assigned a B2 rating to Genesis Energy, L.P.'s (Genesis Energy) proposed senior unsecured notes due 2034. Genesis Energy's existing ratings, including the B1 Corporate Family Rating (CFR), B1-PD Probability of Default Rating (PDR), B2 ratings on its existing senior unsecur...
U.S. Cyber Command Issues Parsons’ Subsidiary Intent to Award for Joint Cyber Hunt Kit (JCHK) Production SealingTech, a Parsons company, was competitively selected for the $500 million contract CHANTILLY, Va., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Sealing Technologies (SealingTech), a Parsons Corporation company (NYSE: PSN), and leading defensive cyber operations solution provider, received an Intent to Award notification from the United States Cyber Command (USCYBERCOM) for a sole-source contract to begin production on the company’s Joint Cyber Hunt Kit solution. The three-year period of p...
Parsons to Present at the Barclays 43rd Annual Industrial Select Conference CHANTILLY, Va., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that Carey Smith, chair, president, and chief executive officer, and Matt Ofilos, chief financial officer, will participate in a fireside chat question and answer session at the Barclays 43rd Annual Industrial Select Conference on Wednesday, February 18, 2026, at approximately 3:35 p.m. Eastern Time. The presentation will be available live via webcast on the investor relations section of Parsons’ website (). A replay...
Moody's Ratings (Moody's) upgraded Genesis Energy, L.P.'s (Genesis Energy) Corporate Family Rating (CFR) to B1 from B2, Probability of Default Rating (PDR) to B1-PD from B2-PD and the ratings on its existing senior unsecured notes to B2 from B3. Concurrently, we changed the company's rating outlook ...
Parsons Reports Fourth Quarter and Fiscal Year 2025 Q4 2025 Financial Highlights Q4 revenue of $1.6 billion decreased 8% year-over-year and 10% on an organic basisTotal revenue growth of 11% and 8% on an organic basis excluding confidential contractNet income of $56 million increased 3% year-over-year, a fourth quarter recordRecord adjusted EBITDA of $153 million increased 5%; adjusted EBITDA margin of 9.6%Cash flow from operations increased 32% to $168 millionBook-to-bill ratio of 0.9x and continued streak of TTM book-to-bill ratio of 1.0x or greater in every quarter since IPO Fiscal Ye...
Parsons Awarded $125M Contract to Support the U.S. Army Combat Capabilities Development Command Army Research Laboratory CHANTILLY, Va., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) has been awarded a $125 million single-award Task Order contract over five years to support the U.S. Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL), High Performance Computing Modernization Program (HPCMP), and Defense Research and Engineering Network (DREN). This recompeted award highlights Parsons’ commitment to advancing research and development in ...
Parsons Secures $91 Million Contract Extension for U.S. Diplomatic Mission Security Worldwide CHANTILLY, Va., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced the company secured a $91 million contract extension for the Overseas Security Installation Services (OSIS II) contract administered by the U.S. Department of State. This is the seventh option year award of a 10-year contract, and part of the broader nearly $1.12 billion OSIS II contract. The extension underscores Parsons’ consistent performance and long-standing reputation as a reliable partner in deliver...
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the closing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par value $0.001, and concurrent private placement of 22,400,000 shares of common stock and 367,145 shares of series b convertible preferred stock (the “Series B Convertible Preferred Stock”). The shares of common stock offered pursuant to the publi...
Parsons’ C-UAS DroneArmor™ Deployed to Protect U.S. Border and National Security CHANTILLY, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced today that DroneArmor™, the company’s counter-unmanned aircraft system (C-UAS), has been deployed by a Federal national security customer to enhance security and protect personnel, communities, and critical infrastructure along the United States southern border. The proven, military-grade command and control (C2) system is purpose-built to provide streamlined and autonomous C-UAS protection. DroneArmor™, a Technology ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.